GE Healthcare and Intel in deal to address rapidly expanding $3bn telehealth market
This article was originally published in Clinica
Executive Summary
GE Healthcare and Intel are jointly investing $250m over five years to develop and market new technologies for independent living and chronic disease management.
You may also be interested in...
HIMSS 2022: GE Introduces Edison Platform To Integrate Clinical Data From Multiple Sources
The Edison Digital Health Platform is a “vendor-agnostic” platform with an integrated AI engine that will allow health care systems to aggregate data from connect devices and other sources.
The Sustainability Stakes Are Rising: ‘We Cannot Recycle Our Way Out Of This’
The journey to Net Zero, described as ‘the defining issue of our time,’ will get harder in the coming decade. Failure to keep up the pressure will result in more long-term health conditions, increasing deaths and higher costs. The UK NHS is a Net Zero exemplar globally, but without a systemic approach, its compliance efforts could stutter.
UK Life Sciences Cautiously Upbeat For Investment Year Ahead – BioWales 2024
Favorable UK biopharma investment trends have been reported by the BioIndustry Association, but can medtech and healthtech share in the positivity? A roundtable at the BioWales in London 2024 event framed the outlook for non-pharma players.